Burden of blood transfusion in knee and hip surgery in the US and Belgium

Journal of Medical Economics

Volumn 12, Issue 3, 2009, Pages 171-179

  Blanchette, Christopher M ^a,b   Joshi, Ashish V ^c   Szpalski, Marek ^d   Gunzburg, Robert ^e   Du Bois, Mark ^f,g   Donceel, Peter ^g   Saunders, William B ^h  

^a LOVELACE RESPIRATORY RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF NORTH CAROLINA   (United States)

^c NOVO NORDISK INC   (United States)

^d FREE UNIVERSITY OF BRUSSELS   (Belgium)

^e Eeuwfeestkliniek   (Belgium)

^f Christelijke Mutualiteit   (Belgium)

^g UNIVERSITY OF LEUVEN   (Belgium)

^h Outcome   (United States)

Author keywords

Blood transfusions; Healthcare costs; Joint surgery; Length of stay

Indexed keywords

APROTININ; DESMOPRESSIN; LOW MOLECULAR WEIGHT HEPARIN; TRANEXAMIC ACID;

AGED; ARTICLE; BELGIUM; BLOOD TRANSFUSION; COST UTILITY ANALYSIS; DESCRIPTIVE RESEARCH; DRUG COST; FEMALE; HEALTH CARE COST; HIP SURGERY; HOSPITALIZATION COST; HUMAN; INTENSIVE CARE UNIT; JOINT PROSTHESIS; KNEE SURGERY; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; REGRESSION ANALYSIS; UNITED STATES;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ARTHROPLASTY, REPLACEMENT, HIP; ARTHROPLASTY, REPLACEMENT, KNEE; BELGIUM; BLOOD TRANSFUSION; CROSS-CULTURAL COMPARISON; FEMALE; HEALTH CARE COSTS; HUMANS; LENGTH OF STAY; MALE; MIDDLE AGED; REGRESSION ANALYSIS; RETROSPECTIVE STUDIES; UNITED STATES; YOUNG ADULT;

EID: 75149160676     PISSN: 13696998     EISSN: None     Source Type: Journal    
DOI: 10.3111/13696990903172760     Document Type: Article

References (32)

1. Goodnough LT, Brecher ME, Kanter MH, et al. Transfusion medicine. First of two parts - blood transfusion. N Engl J Med 1999;340(6):438-447
2. Goodnough LT, Brecher ME, Kanter MH, et al. Transfusion medicine. Second of two parts - blood conservation. N Engl J Med 1999;340(7):525-533
3. Tang R, Chen HH, Wang YL, et al. Risk factors for surgical site infection after elective resection of the colon and rectum: a single-center prospective study of 2,809 consecutive patients. Ann Surg 2001;234(2):181-189
4. Triulzi DJ, Vanek K, Ryan DH, Blumberg N. A clinical and immunologic study of blood transfusion and postoperative bacterial infection in spinal surgery. Transfusion 1992;32(6):517-524
5. Domen RE. Adverse reactions associated with autologous blood transfusion: evaluation and incidence at a large academic hospital. Transfusion 1998;38(3):296-300
6. Goldman M, Remy-Prince S, Trepanier A, Decary F. Autologous donation error rates in Canada. Transfusion 1997;37(5):523-527
7. Hillyer CD, Hart KK, Lackey DA III, et al. Comparable safety of blood collection in "high-risk" autologous donors versus non-high-risk autologous and directed donors in a hospital setting. Am J Clin Pathol 1994;102(3):275-277
8. Linden JV, Kruskall MS. Autologous blood: always safer? Transfusion 1997;37(5):455-456
9. Popovsky MA, Whitaker B, Arnold NL. Severe outcomes of allogeneic and autologous blood donation: frequency and characterization. Transfusion 1995;35(9):734-737
10. CDC. Centers for Disease Control. Red blood cell transfusions contaminated with Yersinia enterocolitica - United States, 1991-1996, and initiation of a national study to detect bacteria-associated transfusion reactions. MMWR Morb Mortal Wkly Rep 1997;46(24):553-555
11. Trouern-Trend JJ, Cable RG, Badon SJ, et al. A case-controlled multicenter study of vasovagal reactions in blood donors: influence of sex, age, donation status, weight, blood pressure, and pulse. Transfusion 1999;39(3):316-320
12. Bryson GL, Laupacis A, Wells GA. Does acute normovolemic hemodilution reduce perioperative allogeneic transfusion? A meta-analysis. The International Study of Perioperative Transfusion. Anesth Analg 1998;86(1):9-15
13. Gillon J, Thomas MJ, Desmond MJ. Consensus conference on autologous transfusion. Acute normovolaemic haemodilution. Transfusion 1996;36(7):640-643
14. Helm RE, Klemperer JD, Rosengart TK, et al. Intraoperative autologous blood donation preserves red cell mass but does not decrease postoperative bleeding. Ann Thorac Surg 1996;62(5):1431-1441
15. Herregods L, Moerman A, Foubert L, et al. Limited intentional normovolemic hemodilution: ST-segment changes and use of homologous blood products in patients with left main coronary artery stenosis. J Cardiothorac Vasc Anesth 1997;11(1):18-23
16. Kahraman S, Altunkaya H, Celebioglu B, et al. The effect of acute normovolemic hemodilution on homologous blood requirements and total estimated red blood cell volume lost. Acta Anaesthesiol Scand 1997;41(5):614-617
17. Kochamba GS, Pfeffer TA, Sintek CF, et al. Intraoperative autotransfusion reduces blood loss after cardiopulmonary bypass. Ann Thorac Surg 1996;61(3):900-903
18. Cavallieri S, Riou B, Roche S, et al. Intraoperative autologous transfusion in emergency surgery for spine trauma. J Trauma 1994;36(5):639-643
19. Reitman CA, Watters WC III, Sassard WR. The Cell Saver in adult lumbar fusion surgery: a cost-benefit outcomes study. Spine 2004;29(14):1580-1583; discussion 1584
20. Laupacis A, Fergusson D. Erythropoietin to minimize perioperative blood transfusion: a systematic review of randomized trials. The International Study of Peri-operative Transfusion (ISPOT) Investigators. Transfus Med 1998;8(4):309-317
21. Alderman EL, Levy JH, Rich JB, et al. Analyses of coronary graft patency after aprotinin use: results from the International Multicenter Aprotinin Graft Patency Experience (IMAGE) trial. J Thorac Cardiovasc Surg 1998;116(5):716-730
22. Florentino-Pineda I, Thompson GH, Poe-Kochert C, et al. The effect of amicar on perioperative blood loss in idiopathic scoliosis: the results of a prospective, randomized double-blind study. Spine 2004;29(3):233-238
23. Garcia-Huete L, Domenech P, Sabate A, et al. The prophylactic effect of aprotinin on intraoperative bleeding in liver transplantation: a randomized clinical study. Hepatology 1997;26(5):1143-1148
24. Kaspar M, Ramsay MA, Nguyen AT, et al. Continuous small-dose tranexamic acid reduces fibrinolysis but not transfusion requirements during orthotopic liver transplantation. Anesth Analg 1997;85(2):281-285
25. Munoz JJ, Birkmeyer NJ, Birkmeyer JD, et al. Is epsilon-aminocaproic acid as effective as aprotinin in reducing bleeding with cardiac surgery?: a meta-analysis. Circulation 1999;99(1):81-89
26. Peters DC, Noble S. Aprotinin: an update of its pharmacology and therapeutic use in open heart surgery and coronary artery bypass surgery. Drugs 1999;57(2):233-260
27. Rich JB. The efficacy and safety of aprotinin use in cardiac surgery. Ann Thorac Surg 1998;66(5)(Suppl):S6-11; discussion S25-18
28. Sethna NF, Zurakowski D, Brustowicz RM, et al. Tranexamic acid reduces intraoperative blood loss in pediatric patients undergoing scoliosis surgery. Anesthesiology 2005;102(4):727-732
29. Urban MK, Beckman J, Gordon M, et al. The efficacy of antifibrinolytics in the reduction of blood loss during complex adult reconstructive spine surgery. Spine 2001;26(10):1152-1156
30. Blanchette CM, Joshi AV, Szpalski M, et al. Comparison between spinal surgery blood transfusion services costs and associated treatment practices in the US and Belgium. Curr Med Red Opin 2007;23(11):2793-2804
31. Blanchette CM, Wang PF, Joshi AV, et al. Cost and utilization of blood transfusion associated with spinal surgeries in the United States. Eur Spine J 2006;16(3):353-363
32. Rosencher N, Kerkkamp HE, Macheras G, et al. Orthopedic Surgery Transfusion Hemoglobin European Overview (OSTHEO) study: blood management in elective knee and hip arthroplasty in Europe. Transfusion 2003;43(4):459-469